MusclePharm Number Of Employees vs. Total Asset

Taking into consideration MusclePharm's profitability measurements, MusclePharm may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess MusclePharm's ability to earn profits and add value for shareholders.
For MusclePharm profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MusclePharm to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MusclePharm utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MusclePharm's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MusclePharm over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Please note, there is a significant difference between MusclePharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if MusclePharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MusclePharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

MusclePharm Total Asset vs. Number Of Employees Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining MusclePharm's current stock value. Our valuation model uses many indicators to compare MusclePharm value to that of its competitors to determine the firm's financial worth.
MusclePharm is considered to be number one stock in number of employees category among its peers. It also is considered to be number one stock in total asset category among its peers fabricating about  533,810  of Total Asset per Number Of Employees. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MusclePharm's earnings, one of the primary drivers of an investment's value.

MusclePharm Number Of Employees vs. Competition

MusclePharm is considered to be number one stock in number of employees category among its peers. The total workforce of Consumer Staples industry is now estimated at about 150,842. MusclePharm adds roughly 21.0 in number of employees claiming only tiny portion of stocks in Consumer Staples industry.

MusclePharm Total Asset vs. Number Of Employees

Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

MusclePharm

Number of Employees

 = 

Full Time

+

Part Time

 = 
21
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

MusclePharm

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
11.21 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

MusclePharm Total Asset Comparison

MusclePharm is currently under evaluation in total asset category among its peers.

MusclePharm Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on MusclePharm. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MusclePharm position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MusclePharm's important profitability drivers and their relationship over time.

Use MusclePharm in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MusclePharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MusclePharm will appreciate offsetting losses from the drop in the long position's value.

MusclePharm Pair Trading

MusclePharm Pair Trading Analysis

The ability to find closely correlated positions to MusclePharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MusclePharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MusclePharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MusclePharm to buy it.
The correlation of MusclePharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MusclePharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MusclePharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MusclePharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your MusclePharm position

In addition to having MusclePharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Realty Funds Thematic Idea Now

Realty Funds
Realty Funds Theme
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in MusclePharm Pink Sheet

If you are still planning to invest in MusclePharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MusclePharm's history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories